Does the COMT rs4680 AA genotype reduce COMT activity and slow catechol estrogen clearance?

Estrogen metabolism and clearance rely heavily on Phase II conjugation to prevent the accumulation of reactive intermediates. The catechol-O-methyltransferase (COMT) gene contains a key functional polymorphism, rs4680, which directly dictates the metabolic clearance rate of catechol estrogens.

Genetic regulation of enzyme activity

• Reduced thermostability: The COMT rs4680 AA (Met/Met) genotype causes a valine-to-methionine substitution at codon 158, reducing protein thermostability at physiological temperatures (37 °C) and accelerating enzyme degradation.
• Diminished capacity: This structural thermolability leads to a 3- to 4-fold (approximately 75%) reduction in functional enzyme activity in vitro, and an approximate 40% reduction in effective in vivo enzyme activity compared to the GG (Val/Val) genotype.

Impact on estrogen clearance and genotoxic risk

• Impaired O-methylation: Under normal conditions, COMT uses S-adenosylmethionine (SAM) to methylate reactive catechol estrogens (2-hydroxyestrone/estradiol and 4-hydroxyestrone/estradiol) into stable, water-soluble methoxyestrogens.
• Metabolic backlog: The reduced activity of the AA genotype impairs this pathway, leading to an elevated hydroxy-to-methoxy estrogen ratio (such as 2-OHE1 to 2-MeOE1) and a slower overall clearance rate of catechol estrogens.
• Genotoxic potential: Slower O-methylation allows catechol estrogens to follow a default pathway, oxidizing into reactive, genotoxic estrogen quinones that form DNA adducts. This metabolic backlog is further exacerbated by epigenetic promoter hypermethylation or depletion of critical methyl donors and cofactors like SAM, magnesium, and folate.

Bottom line

• Bottom line: The COMT rs4680 AA genotype impairs enzyme thermostability and activity, resulting in a 40% to 75% loss of functional capacity that slows the methylation of reactive catechol estrogens, elevates the hydroxy-to-methoxy ratio, and increases exposure to potentially genotoxic estrogen quinones.